nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—AGTR1—artery—metabolic syndrome X	0.217	0.261	CbGeAlD
Forasartan—AGTR1—endothelium—metabolic syndrome X	0.183	0.22	CbGeAlD
Forasartan—AGTR1—blood vessel—metabolic syndrome X	0.169	0.203	CbGeAlD
Forasartan—AGTR1—cardiovascular system—metabolic syndrome X	0.0754	0.0907	CbGeAlD
Forasartan—AGTR1—kidney—metabolic syndrome X	0.0738	0.0887	CbGeAlD
Forasartan—AGTR1—adipose tissue—metabolic syndrome X	0.0665	0.0799	CbGeAlD
Forasartan—AGTR1—liver—metabolic syndrome X	0.0466	0.0561	CbGeAlD
Forasartan—AGTR1—ACE Inhibitor Pathway—ACE—metabolic syndrome X	0.0176	0.135	CbGpPWpGaD
Forasartan—Losartan—ACE—metabolic syndrome X	0.0172	0.445	CrCbGaD
Forasartan—Valsartan—ALB—metabolic syndrome X	0.0144	0.373	CrCbGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—AGT—metabolic syndrome X	0.0111	0.0859	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—NOS3—metabolic syndrome X	0.00818	0.063	CbGpPWpGaD
Forasartan—AGTR1—Arf6 trafficking events—SLC2A4—metabolic syndrome X	0.00736	0.0567	CbGpPWpGaD
Forasartan—Losartan—ALB—metabolic syndrome X	0.00703	0.182	CrCbGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—TGFB1—metabolic syndrome X	0.00541	0.0417	CbGpPWpGaD
Forasartan—AGTR1—Arf6 trafficking events—INS—metabolic syndrome X	0.00414	0.0319	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—metabolic syndrome X	0.00345	0.0266	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00281	0.0217	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00279	0.0215	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.00267	0.0205	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—GHRL—metabolic syndrome X	0.00263	0.0203	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.00252	0.0194	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00239	0.0184	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.00238	0.0184	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00217	0.0168	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—metabolic syndrome X	0.00213	0.0164	CbGpPWpGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00195	0.015	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00193	0.0149	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00186	0.0144	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00182	0.014	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00177	0.0136	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00167	0.0129	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00164	0.0126	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.00162	0.0125	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—metabolic syndrome X	0.00159	0.0122	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TGFB1—metabolic syndrome X	0.00158	0.0122	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TNF—metabolic syndrome X	0.00148	0.0114	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.00146	0.0113	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00142	0.0109	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—GHRL—metabolic syndrome X	0.00134	0.0104	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00133	0.0103	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.0013	0.00999	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CNR1—metabolic syndrome X	0.00127	0.00981	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00108	0.00835	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00103	0.00793	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000987	0.0076	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000934	0.0072	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000893	0.00688	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—AGT—metabolic syndrome X	0.000826	0.00636	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000802	0.00618	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00076	0.00586	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000728	0.00561	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00072	0.00554	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00069	0.00532	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CCL2—metabolic syndrome X	0.00068	0.00524	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000654	0.00504	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000618	0.00476	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000558	0.0043	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000552	0.00425	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000538	0.00414	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RBP4—metabolic syndrome X	0.000538	0.00414	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000536	0.00413	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000507	0.0039	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000505	0.00389	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOC3—metabolic syndrome X	0.000477	0.00367	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000467	0.00359	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—HTR2C—metabolic syndrome X	0.00043	0.00331	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AGT—metabolic syndrome X	0.000424	0.00326	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CYBA—metabolic syndrome X	0.000417	0.00321	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—GHRL—metabolic syndrome X	0.000408	0.00314	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CNR1—metabolic syndrome X	0.000386	0.00297	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000349	0.00269	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF2—metabolic syndrome X	0.000316	0.00243	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOB—metabolic syndrome X	0.000306	0.00236	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCL5—metabolic syndrome X	0.000299	0.00231	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000298	0.0023	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LPL—metabolic syndrome X	0.000293	0.00225	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AGT—metabolic syndrome X	0.00025	0.00193	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEP—metabolic syndrome X	0.000245	0.00189	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOE—metabolic syndrome X	0.000245	0.00189	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—APOA1—metabolic syndrome X	0.000242	0.00187	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IRS1—metabolic syndrome X	0.000219	0.00169	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—INS—metabolic syndrome X	0.00021	0.00161	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CCL2—metabolic syndrome X	0.000206	0.00159	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1—metabolic syndrome X	0.000203	0.00156	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000192	0.00148	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NOS3—metabolic syndrome X	0.000184	0.00142	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000157	0.00121	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6—metabolic syndrome X	0.000155	0.00119	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—AKT1—metabolic syndrome X	0.000143	0.0011	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFB1—metabolic syndrome X	0.000122	0.000936	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6—metabolic syndrome X	9.16e-05	0.000705	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—AKT1—metabolic syndrome X	8.45e-05	0.000651	CbGpPWpGaD
